Copyright
©The Author(s) 2019.
World J Clin Oncol. Aug 24, 2019; 10(8): 283-292
Published online Aug 24, 2019. doi: 10.5306/wjco.v10.i8.283
Published online Aug 24, 2019. doi: 10.5306/wjco.v10.i8.283
Figure 1 Five and 10 years biochemical relapse free survival rates when castrate testosterone level of < 20 ng/dL is used (P = 0.
001).
Figure 2 Five and 10 years biochemical relapse free survival rates when castrate testosterone level of < 50 ng/dL is used (P = 0.
006).
Figure 3 Biochemical relapse free survival rates for patients with different castrate testosterone cut-off values (P = 0.
003).
Figure 4 Receiver operating characteristic curve analyses comparing 2 cut-off castrate testosterone values.
- Citation: Ozyigit G, Hurmuz P, Yuce D, Akyol F. Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer. World J Clin Oncol 2019; 10(8): 283-292
- URL: https://www.wjgnet.com/2218-4333/full/v10/i8/283.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i8.283